http://www.proactiveinvestors.com/companies/news/33538/nanoviricides-says-two-oral-flucide-candidates-as-effective-as-iv-in-animal-study-33538.html
Posted by RLW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment